Document is current

Any future updates will be listed below

Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

Crossref DOI link: https://doi.org/10.1186/s13075-019-1887-x

Published Online: 2019-04-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark